Taylor B. Poston Chlamydia is the most common sexually transmitted bacterial infection in the world, and 75% of infected women never develop symptoms. Furthermore, chlamydia will ascend from the cervix to the upper genital tract in 40% of infected women. This infection of the endometrium puts women at risk for pelvic inflammatory disease and infertility.... Continue Reading →
Hold the sugar: identifying the contributions of high blood glucose to poor cancer outcomes
Tamara Vital We’ve talked at Oncobites about how many factors can cause or contribute to cancer. We’ve discussed how tumors arise from cells that have acquired mutations (could be inherited). Many of these factors have been related to external exposures like UV exposure from the sun or cigarette smoking that cause mutations that contribute to... Continue Reading →
The Sweet Method of Cancer Detection
Kaye Alcedo Time is of the essence when it comes to the battle with cancer. Detecting tumors at an early stage increases the chance of patient survival to more than 80%. However, despite today’s advancing technology, about 48% of patients get diagnosed at a very late stage. This is because screening methods of many, if... Continue Reading →
A CAR-T therapy without the T-cells
Varshit Dusad Imagine a dystopian world. Here, some citizens of an otherwise well-functioning state have gone rogue and are running an anti-national agenda. They are always plundering the natural resources meant to be evenly distributed among the population. They are quite cunning as they start slowly by deviating from the laws of their natural order... Continue Reading →
Vaccines as Cancer Prevention and Therapies
Rachel Cherney Cancer is a complex set of diseases, characterized by uncontrolled growth and metastasis, destroying important organs and bodily systems. It can occur in almost any part of the body, and in most cases, it is impossible to determine how or when it will develop, certain genetically linked cancers perhaps being an exception. Because... Continue Reading →
Kadcyla: The Next Standard in Breast Cancer Therapy?
Taylor A. Johnson October is the official month of breast cancer awareness. Breast cancer is one of the most common forms of cancer, especially in women. Last year alone, the American Cancer Society estimated over 300,000 new cases of breast cancer would develop in men and women, and over 41,000 would pass away from breast... Continue Reading →
Diet-based measures can reduce the risk of cancer- fact or fake news?
Ananya Sen It has been widely proven that there is a correlation between weight and cancer. Being overweight increases the cancer risk 52-62% compared to people with a healthy weight because excess body fat causes an increase in hormones that promote tumor growth. This result begs the question- is there a link between diet and... Continue Reading →
The Reproducibility Crisis
Morgan McSweeney As Alex Woodell recently described, the preclinical research community is in a quiet crisis. Somewhere between 50% and 90% of results from early-stage academic cancer research are unable to be reproduced by industry scientists. Studies by several large multinational pharmaceutical companies and a number of other independent research groups have confirmed what they... Continue Reading →
Cancer Immunotherapy wins the 2018 Nobel Prize
Sara Musetti and Manisit Das Early October is an exciting time of the year when people all over the world turn their eyes to Stockholm to see the winners of the Nobel Prize. Yesterday, James Allison and Tasuku Honjo jointly won the 2018 Nobel Prize in Medicine or Physiology for their work discovering the function... Continue Reading →
Dealing With The Pitfalls of Checkpoint Security
Jason Tetro If you’ve ever traveled internationally, you know you need a passport. This document is your access pass to the world. What you might not know is that this rather plain looking document is filled with a variety of different checkpoints to ensure authenticity. Some passports have biometric chips, others have incorporated images only... Continue Reading →